Радионуклидная диагностика для практических врачей - Лишманова Ю.Б.
ISBN 5-93629-166-9
Скачать (прямая ссылка):
15. Chiti A., Maffioli L.S., Infante M., Grasselli G., Incarbone M., Gasparini M.D., Savelli G., Bombardieri E. Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT// J. Nucl. Med. - 1996. - Vol. 37. - P. 938-942.
16. Chiu M.L., Kronauge J.F., Piwnica-worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts // J. Nucl. Med. - 1990. - Vol. 31. - P. 1646-1653.
17. Danforth D.N. The role of axillary limph node dessection in the management of breast cancer // Principles and Practice of Oncology. - 1992. -Vol. 6.-P. 1-16.
18. Dewan N.A., Gupta N.C., Redepenning L.S., Phalen J.J., Frick M.P. Diagnostic efficacy of FDG-PET imaging in solitary pulmonary nodules // Chest. - 1993. - Vol. 104. - P. 997-1002.
19. Early Breast Cancer Trialists' Collaborative Group // Lancet. - 1992. - Vol. 339. - P. 1-15, 71-85.
20. Edwards C.L., Hayes R.L. Tumor scanning with Ga citrate // J. Nucl. Med. - 1969. - Vol. 10. - P. 103-105.
21. Forrest A.P.M., Everington D., McDonald CC et al. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy // Br. J. Surg. - 1995. - Vol. 82. - P. 1504-1508.
22. Fosburg R.G., Hopkins СВ., Kan M.K. Evaluation of the mediastinum by gallium-67 in lung cancer // J. Thorac. Cardiovasc. Surg. - 1979. -Vol. 77. - P. 76-82.
23. Friedman S., Sullivan K., SaIk D., NeIp W.B., Griep R.J., Johnson D.H., Blend M.J., Aye R., Suppers V, Abrams P.G. Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonaf antibodies // Hematol. Oncol. Clin. North. Am. - 1990. - Vol. 4. - P. 1069-1078.
24. Frisell J. et al. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial // Breast Cancer Res Treat. -1991.-Vol. 18.-P. 49-56.
25. Fujita T. et al. Gene expression of Somatostatin receptor subtypes, SSTRI and SSTR2, in human lung cancer cell lines // Life Sei. - 1994. - Vol. 55.-P. 1797-1806.
26. Prisco G., Fiorenza M., Leonardi L. et al. The technologists contribution to the optimization of lymphoscintigraphy to localize the sentinel node in breast cancer // Eur. J. Nucl. Med. - 2000. - Vol. 27, N.8. - P. 929.
27. Gambhir S.S., Hoh CK., Phelps M.E., Madar I., Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma // J. Nucl. Med. - 1996. - Vol. 37. - P. 1428-1436.
28. Gambhir S.S., Hoh CK., Phelps M.E., Madar 1., Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma // J. Nucl. Med. - 1996. - Vol. 37. - P. 1428-1436.
29. Gdeedo A., Van Schil P., Corthouts B., Van Mieghem F., Van Meerbeeck J., Van Marek E. Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bron-chogenic carcinoma // Eur. J. Cardio-Thorac. - 1997. - Vol. 12. - P. 224-227.
30. Ginsberg R.J. Resection of non-small cell lung cancer // Chest. - 1997. - Vol. 112. - P. 203-205.
31. Harms S.E. et al. Fat-suppressed three dimensional MR imaging of the breast // Radiographics. - 1993. - Vol. 13. - P. 247-267.
32. Harms S.E. et al. MR imaging of the breast with rotating delivery of excitation of resonance: Clinical experience with pathological correlation // Radiology. - 1993. - Vol. 187. - P. 493-501.
33. Hebert M.E., Lowe V.J., Hoffman J.M., Patz E.F., Anscher M.S. Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings //Am. J. Clin. Oncol. - 1996. - Vol. 19. - P. 416-421.
34. Helzlsouer K.J, Epidemiology, prevention and early detection of breast cancer// Curr. Opin. Oncol. - 1994. - Vol. 6. - P. 541-548.
35. HiranoT, Otake H., Yoshida I., Endo К. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA //J. Nucl. Med. - 1995. -Vol. 36. - P. 202-207.
36. Hisada K., Tonami N., Miyamea T., Hiraki Y., Yamazaki T., Maeda I, Nakajo M. Clinical evaluation of tumour imaging with 201T1 chloride // Radiology. - 1978. - Vol. 129. - P. 497-500.
37. Hochstenbag M.M.H., Heidendal G.A.K., Wouters E.F.M., Ten Velde G.P.M. In-111 octreotide imaging in staging of small cell lung cancer// Clin. Nucl, Med. - 1997. - Vol. 22. - P. 811-816.
38. Ihde D.C Chemotherapy of lung cancer// N. Engi. J. Med. - 1992. - Vol. 327. - P. 1434-1441.
39. Izbicki J.R., Passlick В., Pantel K., Pichlmeier U., Hosch S.B., Karg O., Thetter O. Effectiveness of radical systematic medias-tinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial // Ann. Surg. - 1998. - Vol. 227.-P. 138-144.
40. Kalofonos H.P., Sivolapenko G.B., Courtenay-Luck N.S., Snook D.E., Hooker G.R., Winter R., McKenzie CG., Taylor-Papadimitriou J.J., Lavender P.J., Epenetos A.A. Antibody guided targeting of non-small cell lung cancer using 1 "In-labeled HMFG1 F(ab') fragments //Cancer. Res. - 1988. -Vol.48.-P. 1977-1984.
